Incidence and Costs of Hypoglycemia among Type II Diabetes Mellitus Patients in Turkey
- 1 August 2021
- journal article
- Published by SciRes Literature LLC in Journal of Biomedical Research & Environmental Sciences
- Vol. 2 (8), 705-712
- https://doi.org/10.37871/jbres1300
Abstract
We aimed to determine the lifetime and one-year incidence of hypoglycemia in adults who had been treated following a diagnosis of Type II Diabetes Mellitus (T2DM), the factors that affected this incidence, and its effect on the use of health care resources. The descriptive cross-sectional cost study included adult T2DM patients who had an outpatient examination. Using a face-to-face interview method, patients were required to complete a questionnaire containing questions about sociodemographic characteristics, T2DM diagnosis and treatment features, and hypoglycemia events. Episode treatment costs of the patients in whom hypoglycemia was observed were calculated as direct cost per episode from the payer perspective. The mean age of the patients (n = 220) was 48.1 ± 11.8 (range 26-79) years, and the mean duration of disease was 4.5 ± 3.0 (range 1-16) years. According to treatment modalities, the frequency of hypoglycemia in the last year was 4.7% in the patients receiving oral antidiabetic drugs and 32.7% in the patients using insulin. In addition, 61.9% of the patients who had a hypoglycemic event in the last year presented to hospital, and 57.7% of these patients were hospitalized because of the hypoglycemic event. The incidence of hypoglycemia was 18 episodes of hypoglycemia per 100 patient years for T2DM patients and 25 severe hypoglycemia episodes per 100 patient years for patients using insulin. Significant predictors of hypoglycemia included insulin therapy (p = 0.000), regular use of medications (p = 0.013), hospitalization in the last year (p = 0.008), and exercise (p = 0.042). The average cost of a hypoglycemic event was calculated as Purchasing Power Parity İn Dollars ($PPP) 1.370.2 ± 1.407.0 (149.8-5,048.8). T2DM complications are the cause of a high economic burden. Hypoglycemia, which is one of these complications, is observed more frequently in patients who receive insulin therapy, who use regular medication, who do not exercise regularly, and who have been hospitalized in the last year.Keywords
This publication has 16 references indexed in Scilit:
- Hypoglycemia is More Common Among Type 2 Diabetes Patients with Limited Health Literacy: The Diabetes Study of Northern California (DISTANCE)Journal of General Internal Medicine, 2010
- Severe Hypoglycaemia Leading to Hospital Admission in Type 2 Diabetic Patients Aged 80 Years or OlderExperimental and Clinical Endocrinology & Diabetes, 2010
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyBMJ, 2010
- Costs of managing severe hypoglycaemia in three European countriesJournal of Medical Economics, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesThe New England Journal of Medicine, 2009
- The Barrier of Hypoglycemia in DiabetesDiabetes, 2008
- Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) StudyDiabetes, Obesity and Metabolism, 2008
- Trends and Disparities in U.S. Emergency Department Visits for Hypoglycemia, 1993–2005Diabetes Care, 2008
- Frequency and predictors of hypoglycaemia in Type 1 and insulin‐treated Type 2 diabetes: a population‐based studyDiabetic Medicine, 2005
- Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureasArchives of Internal Medicine, 1997